Filter
1234
Text search:
human
pharmaceutical
products
Featured
Recommendations
118
New Publications
332
Language
Document type
No document type
595
Studies & Reports
263
Guidelines
192
Manuals
72
Strategic & Response Plan
69
Training Material
15
Fact sheets
13
Situation Updates
8
Resource Platforms
4
Brochures
2
Infographics
1
Countries / Regions
Kenya
60
Global
51
Ethiopia
40
India
37
Nigeria
27
South Africa
27
Sierra Leone
26
Western and Central Europe
26
Uganda
24
Liberia
23
Rwanda
22
Ghana
21
Namibia
20
Zambia
18
Tanzania
18
Ukraine
17
Philippines
15
Africa
15
Nepal
14
Bangladesh
12
Malawi
12
Latin America and the Carribbean
12
Eastern Europe
12
Zimbabwe
11
Indonesia
11
Lesotho
9
Myanmar / Burma
9
Eswatini/ Swaziland
8
West and Central Africa
7
Burkina Faso
6
Syria
6
Botswana
6
Eastern Europe and Central Asia
6
Asia
6
Cambodia
5
East and Southern Africa
5
Senegal
4
Congo, Democratic Republic of
4
Cameroon
4
Haiti
4
South–East Asia Region
4
Guinea
3
Jordan
3
Thailand
3
Mozambique
3
Sudan
3
North Macedonia
3
Venezuela
3
Russia
3
North America
3
Mali
2
USA
2
Pakistan
2
South Sudan
2
China
2
Benin
2
Central African Republic
2
Brazil
2
Middle East and North Africa
2
Fiji
2
Albania
2
Laos
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Vietnam
2
Jamaica
2
Saudi Arabia
1
Niger
1
Somalia
1
Iraq
1
Afghanistan
1
Germany
1
Lebanon
1
Egypt
1
Papua New Guinea
1
Serbia
1
Libya
1
Madagascar
1
Western Pacific Region
1
Armenia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
504
Clinical Guidelines
89
Key Resources
64
Public Health
59
Women & Child Health
33
Pharmacy & Technologies
24
Capacity Building
9
Annual Report MEDBOX
1
Toolboxes
AMR
159
Pharmacy
130
COVID-19
72
TB
57
HIV
51
Mental Health
46
Planetary Health
38
NTDs
34
Rapid Response
28
Global Health Education
26
Conflict
22
NCDs
22
Caregiver
20
Health Financing Toolbox
19
Ebola & Marburg
17
2.0 Rapid Response
15
Malaria
13
Disability
9
Refugee
7
Specific Hazards
6
Polio
5
Natural Hazards
5
Zika
3
The Multi-professional Patient Safety Curriculum Guide (2011) was developed to assist in the teaching of patient safety in universities and schools in the fields of dentistry, medicine, midwifery, nursing and pharmacy. It also supports the on-going training of all health care professionals.
The C
...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health sector policy. Indeed, medicines play an important role in protecting, maintaining and restoring th
...
Evaluation report
January 2014
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
16-17 march 2015, Geneva, Switzerland
Meeting report
Indian markets caused a stir across the country.1
According to the Centre for Science and the Environment (CSE), a respected New Delhi-based NGO, most honey brands
sold in India contained varying amounts of antibiotics. Their consumption over time could induce resistance to antibiotics,
putting p
...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
Guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace
Accessed November 2017
It is impossible to address the many complex needs of respiratory virus surveillance with a single surveillance system. Multiple systems, investigations and studies must each be fit-for-purpose to specific priority surveillance objectives, and only together can they provide essential information to
...
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen
...
